Apeloa Pharmaceutical Co.,Ltd
000739
株式のランク
#4290
Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical... Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical enterprise, specializing in the discovery, development, production, and global distribution of a diverse range of medicinal products. Its market reach spans China and various international territories. The company strategically focuses its product portfolio on several critical medical fields, including cardiovascular and cerebrovascular health, anti-infective treatments, antiviral therapies, and oncology (cancer treatment), alongside other therapeutic categories. Apeloa's offerings encompass finished pharmaceutical preparations, raw material intermediates (active pharmaceutical ingredients and their precursors), and veterinary medicines. These products are primarily recognized and sold under key brands such as Tianliwei, Beshin, Yosemade, and Jutai, among others. Furthermore, the company extends its expertise to other pharmaceutical businesses by providing contract research, development, and manufacturing (CDMO) services. The corporate headquarters for Apeloa Pharmaceutical Co.,Ltd are located in Dongyang, China.
株価
$3.13
時価総額
$3.62B
変化（1日）
-1.42%
変化（1年）
46.59%
国
CN
取引 Apeloa Pharmaceutical Co.,Ltd (000739)
カテゴリー
Healthcare
Apeloa Pharmaceutical Co.,Ltd（000739）の株式分割履歴
Apeloa Pharmaceutical Co.,Ltd株（シンボル：000739）は合計で6回の株式分割を実施しました。
最新の株式分割はMay 30, 2014に行われました。
Jul 02, 1998より前に購入された000739株は、現在10.53000739株に相当します。
最新の株式分割はMay 30, 2014に行われました。
Jul 02, 1998より前に購入された000739株は、現在10.53000739株に相当します。
株式分割一覧
| 年 | 株式分割 | 分割比率 | 累積分割比率 |
|---|---|---|---|
| 2014-05-30 | 13:10 | x1.3 | x10.53 |
| 2013-06-21 | 2:1 | x2 | x8.1 |
| 2007-07-05 | 3:2 | x1.5 | x4.05 |
| 2006-02-15 | 5:4 | x1.25 | x2.7 |
| 1999-05-28 | 9:5 | x1.8 | x2.16 |
| 1998-07-02 | 6:5 | x1.2 | x1.2 |
類似企業または競合他社の株式分割
| 企業 | 株式分割の回数 | 累積分割比率 | 国 |
|---|---|---|---|
| 0 | - |
DE
|
|
| 0 | - |
DE
|
|
| 0 | - |
JP
|
|
| 0 | - |
CH
|
|
| 5 | x119 |
IN
|
